DRG Successful Exhibit and Training at Arab Health 2016!

Feb 12, 2016Events

The DRG Group recently exhibited at the largest healthcare exhibition & congress in the Middle East: ARAB HEALTH from January 25 – 28, 2016 with great success! In addition to the presentation of several new assays DRG offered live demonstrations of our fully automated random access analyzer:

DRG:HYBRiD-XL®. Visitors from around the world gathered to receive personalized presentations of the Hybrid-XL instrument and DRG also displayed our newest ELISA kits like DHT-optimized (DiHydroTestosterone) and Hepcidin 25 (bioactive) High Sensitive ELISA kit.

Untitled (1)

DRG hosted the second annual DRG:HYBRiD-XL® training workshop in Dubai immediately following the Arab Health exhibition. The training ran from January 30-31 at the J.W. Marriot Marquis Hotel in downtown Dubai.

The workshop was led by Mr. Simon Middleton, DRG Director of Automation and Mr. Wilhelm Sanger, General Manager of DRG Instruments, GmbH. The primary objective of these workshops is to familiarize business partners and distributors with the DRG:HYBRiD-XL®. The training is two-fold: Engineers and Technicians are trained on all technical aspects of the DRG:HYBRiD-XL® in order for he or she to handle all service calls in their respective territories. Engineers received official DRG:HYBRiD-XL® Technical Certfication upon completion of the training. Sales and Management Personnel received sales and marketing training in order to gain the confidence and know-how to properly promote, market, and sell the DRG:HYBRiD.XL in their respective territories.

Untitled2 (1)

The DRG Group thanks all attendees for their ongoing support and interest! If you are interested in attending a DRG:HYBRiD-XL® workshop event in the future, and becoming an authorized DRG:HYBRiD-XL® distributor in your territory, please contact Gregory Guest at [email protected] for more information.

Untitled3 (1)

[starbox]

News and Updates

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.